Clinical Trials for Use of Melatonin to Fight Against COVID-19 Are Urgently Needed

Overview

Journal Nutrients

Date 2020 Aug 28

PMID 32847033

Citations 38

Authors

Konrad Kleszczynski

Andrzej T Slominski

Kerstin Steinbrink

Russel J Reiter

Affiliations

Soon will be listed here.

Abstract

The recent pandemic of COVID-19 has already infected millions of individuals and has resulted in the death of hundreds of thousands worldwide. Based on clinical features, pathology, and the pathogenesis of respiratory disorders induced by this and other highly homogenous coronaviruses, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response contribute to COVID-19 pathology; these are caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This leads to a cytokine storm and subsequent progression triggering acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), and often death. We and others have reported melatonin to be an anti-inflammatory and anti-oxidative molecule with a high safety profile. It is effective in critical care patients by reducing their vascular permeability and anxiety, inducing sedation, and improving their quality of sleep. As melatonin shows no harmful adverse effects in humans, it is imperative to introduce this indoleamine into clinical trials where it might be beneficial for better clinical outcomes as an adjuvant treatment of COVID-19-infected patients. Herein, we strongly encourage health care professionals to test the potential of melatonin for targeting the COVID-19 pandemic. This is urgent, since there is no reliable treatment for this devastating disease.

Citing Articles

Melatonin's Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective.

Bertollo A, Dalazen J, Cassol J, Hellmann M, Mota T, Ignacio Z J Mol Neurosci. 2024; 74(4):113.

PMID: 39636363 DOI: 10.1007/s12031-024-02292-6.

Investigating the Effectiveness of Melatonin in the Treatment of Critically Ill Patients with COVID-19 Hospitalized in the Intensive Care Unit: A Double-Blind Randomized Clinical Trial.

Tirkan A, Eskandari D, Roham M, Aloosh O, Ramim T, Afshar H Med J Islam Repub Iran. 2024; 38:41.

PMID: 39416373 PMC: 11480672. DOI: 10.47176/mjiri.38.41.

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome.

Zheng N, Long Y, Bai Z, Li J, Wang H, Song D J Transl Med. 2024; 22(1):58.

PMID: 38221609 PMC: 10789006. DOI: 10.1186/s12967-023-04779-z.

Neurological damages in COVID-19 patients: Mechanisms and preventive interventions.

Sarkar S, Karmakar S, Basu M, Ghosh P, Ghosh M MedComm (2020). 2023; 4(2):e247.

PMID: 37035134 PMC: 10080216. DOI: 10.1002/mco2.247.

Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial.

Ameri A, Frouz Asadi M, Ziaei A, Vatankhah M, Safa O, Kamali M Inflammopharmacology. 2022; 31(1):265-274.

PMID: 36401728 PMC: 9676876. DOI: 10.1007/s10787-022-01096-7.

References

Michaelides M, Stover N, Francis P, Weleber R . Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol. 2011; 129(1):30-9. DOI: 10.1001/archophthalmol.2010.321. View

Srinivasan V, Spence D, Moscovitch A, Pandi-Perumal S, Trakht I, Brown G . Malaria: therapeutic implications of melatonin. J Pineal Res. 2009; 48(1):1-8. DOI: 10.1111/j.1600-079X.2009.00728.x. View

Tan D, Reiter R, Manchester L, Yan M, El-Sawi M, Sainz R . Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002; 2(2):181-97. DOI: 10.2174/1568026023394443. View

Kleszczynski K, Tukaj S, Kruse N, Zillikens D, Fischer T . Melatonin prevents ultraviolet radiation-induced alterations in plasma membrane potential and intracellular pH in human keratinocytes. J Pineal Res. 2012; 54(1):89-99. DOI: 10.1111/j.1600-079X.2012.01028.x. View

Sanchez-Lopez A, Ortiz G, Pacheco-Moises F, Mireles-Ramirez M, Bitzer-Quintero O, Delgado-Lara D . Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis. Arch Med Res. 2019; 49(6):391-398. DOI: 10.1016/j.arcmed.2018.12.004. View

Hardeland R, Cardinali D, Srinivasan V, Spence D, Brown G, Pandi-Perumal S . Melatonin--a pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 2011; 93(3):350-84. DOI: 10.1016/j.pneurobio.2010.12.004. View

Chen H, Chang C, Lin K, Sung P, Chai H, Zhen Y . Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury. Am J Transl Res. 2014; 6(5):439-58. PMC: 4212921. View

Reiter R, Tan D, Rosales-Corral S, Galano A, Zhou X, Xu B . Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. Molecules. 2018; 23(2). PMC: 6017324. DOI: 10.3390/molecules23020509. View

Shafiei E, Bahtoei M, Raj P, Ostovar A, Iranpour D, Akbarzadeh S . Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial. Medicine (Baltimore). 2018; 97(30):e11383. PMC: 6078764. DOI: 10.1097/MD.0000000000011383. View

10.

Reiter R, Tan D, Zhou Z, Cruz M, Fuentes-Broto L, Galano A . Phytomelatonin: assisting plants to survive and thrive. Molecules. 2015; 20(4):7396-437. PMC: 6272735. DOI: 10.3390/molecules20047396. View

11.

Rogers M, Williams J . Quis Custodiet Ipsos Custodes? Regulation of Cell-Mediated Immune Responses Following Viral Lung Infections. Annu Rev Virol. 2018; 5(1):363-383. DOI: 10.1146/annurev-virology-092917-043515. View

12.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

13.

Tan D, Manchester L, Qin L, Reiter R . Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics. Int J Mol Sci. 2016; 17(12). PMC: 5187924. DOI: 10.3390/ijms17122124. View

14.

Lewis S, Pritchard M, Schofield-Robinson O, Alderson P, Smith A . Melatonin for the promotion of sleep in adults in the intensive care unit. Cochrane Database Syst Rev. 2018; 5:CD012455. PMC: 6353085. DOI: 10.1002/14651858.CD012455.pub2. View

15.

Channappanavar R, Fehr A, Vijay R, Mack M, Zhao J, Meyerholz D . Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2):181-93. PMC: 4752723. DOI: 10.1016/j.chom.2016.01.007. View

16.

Sun C, Lee F, Kao Y, Chiang H, Sung P, Tsai T . Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. J Pineal Res. 2014; 58(2):137-50. DOI: 10.1111/jpi.12199. View

17.

Nduhirabandi F, Lamont K, Albertyn Z, Opie L, Lecour S . Role of toll-like receptor 4 in melatonin-induced cardioprotection. J Pineal Res. 2015; 60(1):39-47. DOI: 10.1111/jpi.12286. View

18.

Tan D, Manchester L, Terron M, Flores L, Reiter R . One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res. 2007; 42(1):28-42. DOI: 10.1111/j.1600-079X.2006.00407.x. View

19.

Kleszczynski K, Zwicker S, Tukaj S, Kasperkiewicz M, Zillikens D, Wolf R . Melatonin compensates silencing of heat shock protein 70 and suppresses ultraviolet radiation-induced inflammation in human skin ex vivo and cultured keratinocytes. J Pineal Res. 2014; 58(1):117-26. DOI: 10.1111/jpi.12197. View

20.

Wang M, Wei C, Wang W, Wang J, Zhang J, Wang J . Melatonin attenuates lung ischaemia-reperfusion injury via inhibition of oxidative stress and inflammation. Interact Cardiovasc Thorac Surg. 2018; 26(5):761-767. DOI: 10.1093/icvts/ivx440. View